CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


23-November-2010
Cerilliant Introduces New Certified Spiking Solution® of N-Desethylamiodarone-D4 HCl

N-Desethylamiodarone-D4 HCl, D-056
100 ug/mL (as free base) in Methanol

A Certified Spiking Solution® and stable-labeled internal standard for use in therapeutic drug monitoring analyses by LC/MS. N-Desethylamiodarone is the primary, active metabolite of amiodarone, an antiarrhythmic agent marketed as Pacerone, Cordarone, Aratac, or Atlansi. N-Desethylamiodarone and amiodarone are monitored by clinical labs to ensure patients remain within the drug’s therapeutic range.

In addition to amiodarone (A-060), its stable-labeled internal standard (A-083) and native N-Desethylamiodarone (D-055), we offer certified solution standards of other antiarrhythmic drugs as well as antihypertensive and cardiac drugs. We also offer Certified Spiking Solutions® of numerous drugs assayed in therapeutic drug monitoring.


Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO 17034 and ISO/IEC 17025 & certified ISO 9001.


All New Product Announcements


© 2020 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
MilliporeSigma is a business of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn